SceneRay Revenue and Competitors

Suzhou,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SceneRay's estimated annual revenue is currently $4M per year.(i)
  • SceneRay's estimated revenue per employee is $251,000

Employee Data

  • SceneRay has 16 Employees.(i)
  • SceneRay grew their employee count by -45% last year.

SceneRay's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is SceneRay?

SceneRay is an innovative high-tech medical device company integrating R & D, production and sales of deep brain stimulation systems. It has complete independent intellectual property rights and continuously develops new technologies and products. The company's goal is to become an international high-end technology and competitive medical device company, so that more patients can enjoy the treatment effect of high-tech medical technology. We will work closely with clinicians and experts to provide patients with high-quality high-tech products and after-sales service. SceneRay has a senior management team consisting of core technical experts, production experts, and company operation experts who have full knowledge of deep brain stimulation. These experts have accumulated rich experience after years of work in related fields in China and abroad. At present, the team members are mainly composed of senior graduates from Tsinghua, Peking University, Fudan, Jiaotong University and other famous universities. The company including manufacturing site is located in Biobay, Suzhou Industrial Park with beautiful environment.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$4M

Revenue (est)

-45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SceneRay News

2022-04-20 - Jingyu medical deep brain electrical stimulation technology for ...

Sceneray's dual target deep brain stimulation (DBS) technology for the treatment of drug addiction indications has obtained the breakthrough...

2022-04-19 - Deep Brain Stimulation (DBS) Devices Market Size, Share ...

... (DBS) Devices Market Size, Share, Outlook And Forecast 2022-2030| Key Players – Beijing Pins, Boston Scientific, Medtronic, SceneRay.

2022-04-17 - Woman admits killing her father because of 'voices in her head'

Dixon was found upstairs in the address...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M18-14%N/A
#2
$5.4M278%N/A
#3
$11.8M4618%N/A
#4
$7.4M4820%N/A
#5
$6.9M53-2%N/A